CT
JAZZ icon

Chicago Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Chicago Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$211K Buy
+913
New +$226K 0.03% 351
2021
Q3 		– Sell
-2,875
Closed -$511K – 338
2021
Q2 		$511K Buy
+2,875
New +$498K 0.12% 178

Other funds holding JAZZ

LSV Asset Management
LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.8B AUM 33.92% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Chicago Trust's JAZZ Position: Q3 2026 in Review

Chicago Trust opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2026: 913 shares worth $211K. The stake represents 0.03% of the portfolio and ranks #351 among its holdings. This is a return to the name: Chicago Trust previously reported a position in JAZZ as recently as Q2 2021.

Chicago Trust first reported a position in JAZZ in Q2 2021 and has held it in 2 quarters since. The position peaked at $511K in Q2 2021. 331 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Chicago Trust held 913 shares of Jazz Pharmaceuticals worth $211K as of Q3 2026.
  • Jazz Pharmaceuticals was a new Chicago Trust position in Q3 2026.
  • Jazz Pharmaceuticals made up 0.03% of Chicago Trust's portfolio in Q3 2026, its #351 holding.
  • Chicago Trust first reported a position in Jazz Pharmaceuticals in Q2 2021 and has held it in 2 quarters since.
  • Chicago Trust's Jazz Pharmaceuticals position peaked at $511K in Q2 2021.
  • 331 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Chicago Trust's 13F filing for Q3 2026, filed 28 Oct 2026.